1. Home
  2. AAT vs RAPP Comparison

AAT vs RAPP Comparison

Compare AAT & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$20.86

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$36.57

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
RAPP
Founded
1967
2022
Country
United States
United States
Employees
208
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2010
2024

Fundamental Metrics

Financial Performance
Metric
AAT
RAPP
Price
$20.86
$36.57
Analyst Decision
Sell
Strong Buy
Analyst Count
2
6
Target Price
$19.50
$48.50
AVG Volume (30 Days)
312.5K
329.4K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
6.57%
N/A
EPS Growth
N/A
24.34
EPS
0.92
N/A
Revenue
$436,204,000.00
N/A
Revenue This Year
$4.33
N/A
Revenue Next Year
$0.22
N/A
P/E Ratio
$22.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$7.73
52 Week High
$21.40
$42.27

Technical Indicators

Market Signals
Indicator
AAT
RAPP
Relative Strength Index (RSI) 73.36 62.24
Support Level $18.44 $25.48
Resistance Level $21.08 $41.59
Average True Range (ATR) 0.32 1.91
MACD 0.14 -0.01
Stochastic Oscillator 98.78 54.92

Price Performance

Historical Comparison
AAT
RAPP

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: